Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just one simply question: Who told us about releasing financial s? Is it only some theory / rumor / wish from here (IHub board or Ihub poster) or did Larry said / write it in some PR? Everybody here is talking about financial report, but where did it came from? Thanks
Sorry man, but this campaign is still running - you can not think that one day you start the campaign and next day you will have a lot of investors putting their money in - this is not how it works - IMHO - the campaign is for long run
Maybe he just needed to buy some gas at the station :) Just kidding - don´t take me serious LOL
New Prostate Cancer Test is Ready for Commercialization Following Successful Completion of Final Clinical Trials
Health Discovery Corporation’s New Molecular Diagnostic Test for Prostate Cancer Successfully Performs at 90% Sensitivity and 97% Specificity in Double-Blind Clinical Trial
SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (“HDC”) (OTCBB: HDVY) today announced that HDC’s new gene-based molecular diagnostic test for prostate cancer has now successfully completed it’s Phase III double-blind clinical trial and is now ready for commercialization to be used by physicians on their patients at risk of having prostate cancer. The new prostate cancer test will be performed at Clarient’s Clinical Laboratory in Aliso Viejo, CA. HDC will receive 30% royalty on each test performed.
Results from Phase I, Phase II and Phase III double-blinded clinical validation studies now completed with prostate tissues obtained from multiple sites, including those tested in collaboration with MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells (clinically significant cancer), as well as, normal and BPH (benign prostatic hyperplasia) cells. To date, 322 prostate tissues have been tested. The combined results of the recently completed double-blinded clinical validation studies demonstrated that the new gene-based molecular diagnostic test for prostate cancer achieved a Sensitivity of 90% for correctly identifying the presence of Grade 3 or higher prostate cancer cells, and a Specificity of 97% for correctly identifying non-cancer cells (normal and BPH), representing an overall test accuracy of 93%.
“We are very pleased with the final results of the double-blind clinical trial and are excited to have our first revenue producing molecular diagnostic test ready for commercialization,” stated Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation. “The successful development, validation and commercialization of this new molecular diagnostic test for prostate cancer proves that HDC, by combining our patented SVM and SVM-RFE technology and our expert Scientific Team, has the ability to produce new molecular diagnostic and prognostic tests which are the future of personalized medicine. Our patent protected discovery method allows us to develop molecular diagnostic and prognostic tests that are free of outside intellectual property rights and thereby allows HDC to fully patent protect our molecular diagnostic gene signatures. Using the same expertise of our Scientific Team and the HDC patented technology, we are currently developing additional new molecular diagnostic tests in a variety of other cancers some of which we hope will be commercially available in Q4 of 2008.”
Dr. Barnhill continued “We are pleased to have HDC’s new gene-based prostate cancer test enter the market like similar molecular diagnostic tests based on unique gene expression profiles such as OncotypeDX from Genomic Health, Inc. (NasdaqGM:GHDX) and MammaPrint from Agendia.”
In the United States alone there are over 1 million prostate cancer tissue biopsy procedures performed annually. Approximately 25% of these tissue biopsies are reported “positive” indicating the presence of prostate cancer. The other 75% of prostate cancer tissue biopsies are reported as “negative” for the presence of cancer. However, one-third of the men with initial prostate cancer tissue biopsies that are reported as “negative” for prostate cancer (roughly 25% of men at risk of having prostate cancer) actually do have prostate cancer that was missed by the first biopsy (False Negative). These men actually have prostate cancer that was missed by the initial tissue biopsy for a variety of reasons. Health Discovery Corporation’s prostate cancer molecular diagnostic test is a genomics based test that should be performed on the 75% of men (approximately 600,000 men annually in the US alone) with initial biopsies reported as negative to assist physicians in identifying those men who could have prostate cancer that was missed by the first biopsy.
“The excellent results seen in Phase I, Phase II, and Phase III double-blinded clinical trials validate the scientific accuracy and robustness of the HDC gene-based molecular diagnostic test for prostate cancer,” stated Dr. Herbert Fritsche, Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, M.D. Anderson Cancer Center in Houston, Texas. “Physicians that are diagnosing and treating prostate cancer patients will be greatly assisted by the additional information that this new prostate cancer test will add to their decision making process.”
In a Press Release issued yesterday, Ron Andrews, CEO of Clarient stated “We are very impressed with the results from these validation studies, and I applaud the development teams from both Clarient and HDC for their diligent efforts in bringing this new test through the validation phase significantly ahead of schedule. The early results from these studies confirm our belief that this powerful genomics-based test may provide physicians with useful information to ensure that men with prostate cancer get a more accurate diagnosis sooner and minimize the need for unnecessary biopsies.”
HDC plans to immediately begin presenting papers for publication and presentations at upcoming meetings as we initiate the marketing phase of commercialization. Because of the clinical trial success of this prostate cancer test, the company plans to initiate a study utilizing urine samples to potentially expand the indication of this new prostate cancer test to be used as a screening tool, which could significantly expand the current market opportunity to include all men at risk for prostate cancer.
About Health Discovery Corporation
Savannah-based Health Discovery Corporation (OTCBB: HDVY) is uniquely positioned in the field of pattern recognition technology. Through the application of its patent protected technology, HDC is a leader in SVM-based molecular diagnostic and prognostic test development in genomics and proteomics, as well as, digital image analysis in pathology and radiology. The Company's SVM and FGM pattern recognition tools have significant application potential in other sizable commercial markets such as oil exploration, financial markets, Internet search and spam, homeland security, and other areas where analysis of large volumes of complex data is required. www.healthdiscoverycorp.com
This news release contains "forward-looking statements" within the meaning of Section 27a of the Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the management team of HDC believes that the expectations reflected in such forward-looking statements are reasonable, they can give no assurance that such expectations will prove correct.
Contacts
Health Discovery Corporation
Stephen D. Barnhill, MD, CEO, 912-443-1987
sbarnhill@healthdiscoverycorp.com
www.healthdiscoverycorp.com
Sharing
* Digg
* del.icio.us
* Newsvine
* Reddit
* Google
* Yahoo
*
PermalinkPermalink
Permalink
To save a permanent link to this news, right-click the date and time (Ctl-click on a Mac) and choose the command to copy the link, link location or shortcut.
So you should write them to stop the PPS :)
Always look on the bright side of life....(this is part of the text from one song)
Few bucks? I think product lunch will probably need more them few bugs :) But maybe I am wrong - not bashing here - just wanted to know what can I wait from the company
I was just thinking - they will need capital for product lunch, don´t they? So IHMO we can wait for some kind of public offering, share dilution or some investors coming in - They have to clear up, how they are going to rise capital
Looks like somebody want us at 2,22 PPS - yesterday after-hours and today pre-market in 2,22 area - but just small volume - my guess is, we will touch it today again in normal trading hours...
Good news, bad news (from yahoo board):
Good news: wattage reduction, size reduction, shock test on WIDE angle, lots of interest, enough money 'till the end of '09.
Bad news- supply chain not ready
Stand alone 2d half 2009 in mass quantities
Embedded - 2010
Eye Wear - 2011
Automotive - 2012
He is like me LOL :) I have a LOT of confidence in MVIS too :)
ps: I am curious what we will hear from company today
That is why it will be useful to have weekly reports about T/A - especially numbers of restricted shares - IMHO
It is just my opinion - we don´t know, who has them and also we don´t know what was the condition how they get them - and IHMO there is the possibility that they can be dumping them - what we know if they didn´t get them for 1 cent? I think there is the possibility they are dumping them - who else can it be? And if we have weekly T/A reports, we can see it. For example: in 1 week we will see change 1 mil. of rest. shares into normal and we will see increased volume in trading - I thing none of long is selling at these prices (at least not in big volume) - so big volume in traded shares = company can be selling (is not now, because they ungagged T/A, or somebody else with big stake (for example owners of restricted shares)
- btw. almost everybody is asking here who can be selling at these prices (my idea is that owners of rest. shares can be)
I think we all will appreciate it - and if nobody not - don´t care about them - Few of us always will :)
IHMO - selling will be over, when restricted shares will turn into normal - I don´t know the origin of restricted shares, but it is probably from past - what we need is to check the T/A regularly and there we will see the change...
Cork - what about you? The weekly reports of T/A? Is it possible? Or somebody else? I am not from USA, so I can´t check it properly
Thanks - still trying to understand :) It all makes sense
Just curious - why Prospect is /was not listed on list of institutional holders? They should be, or not?
http://www.nasdaq.com/asp/holdings.asp?symbol=DPDW&selected=DPDW
Will we see any SEC filling about their today´s transaction? Do they have to report it, or not?
Sorry - don´t understand me bad - I just don´t know where to find it...how do we know they were shorting here? Where is it written? Thanks
I think the same - we have to be patience - some people are playing now, so we have to wait...patience is your friend
IMHO - it was buy AND sell - Somebody sold it, somebody bought it :)
Funny - we have some pre-market here - 1000 shares at 1,54 at 8,02 am - somebody was lucky today
That rise in short:
All companies that joined Russel Index 3000 have increased short position (the size of increase is almost the same like number of shares traded that day they joied the Index) I don´t know what is the reason, but I noticed that at others companies too
Run! Forest Run! LOL
sorry for OT
You don´t like bbq´ing at the gas station? :)
What is the bid / ask? thanks
dilution:
http://www.investopedia.com/terms/d/dilution.asp
restricted shares:
http://www.investopedia.com/terms/r/restrictedstock.asp
Good good - thanks for asking :)
Some fun stuff from yahoo board: - be sure you read the last sentence before you buy MVIS :)
Sony Group to Spearhead Microvision Sales in Japan. First Asian Distributor for Laser Displays"
Publication: Business Wire
Date:Thursday, July 24th 2008
Subject: Electronic components industry, Electronics industry
Company: Microvision Inc.
Location: Japan, United States
REDMOND, Wash.--(BUSINESS WIRE)--July 24th, 2008
Microvision, Inc. (Nasdaq:MVIS), a leader in light scanning technologies, today announced that it has entered into an agreement with Sony Group, a division of The Sony Corporation, to represent and sell Microvision's display products and technology capabilities in Japan.
The Sony Group will coordinate the delivery of end-to-end display system solutions featuring Microvision's IPM (Integrated Photonics Module) and other display systems tailored to the specific needs of hanheld electronics, entertainment, defense, aviation and industrial customers in the Japanese market. These efforts will focus on sales, technician support systems for general maintenance, repair and overhaul (MRO) applications as well as unique high value display solutions to the Japanese cellular market.
A long-time leader in Japan, Sony Group tailors to the needs of Sony Corporation and other heavy hitters doing business in Japan. Customers include such notable companies as Mitsubishi, Kawasaki, Fuji, Toshiba, NEC, Hitachi, Japan Airlines and various divisions of the Japanese defense and civil service agencies.
"The Sony Group agreement offers Microvision the ability to provide display technology and products to electronic, industrial, and aviation OEM's, and to defense and government clients in the Japanese market through a highly regarded trading house," stated Alexander Tokman, Microvision's president. "Furthermore, the Sony Group provides Microvision with a unique window into other Sony operating groups. We expect this to facilitate additional relationships as opportunities are developed. We are confident that we have partnered with a strong marketing force to address the many opportunities in Japan."
Prior to completing this agreement, the United States government must apologize for the Hiroshima / Nagasaki incident.
Hmm - weird - It was working at time I was posting it - but there was nothing written - just some tests articles
Maybe they were just trying to start it again :)
Sorry buddy - they were mine :) I was waiting for filling for few days - finally I got them :)
New blog about Microvision just started - Aware - maybe you can add it into Ibox? Thanks
http://www.microvision.com/blog/
So now they are not only pumping oil, but also pumping the PPS - LOL ....just kidding :)
We will see how it will do in next days - i read somewhere, that next week we can see a PR about next CC - I hope they will make some thinks clear by that occasion
I just don´t get it why it rise so much, so quickly and on such a low volume...I like that we are near 3 USD range, but i am little bit worried about it - sorry for that negative look :)
I just read it at google so i post it :)
Deep Down Inc (DPDW.PK) newly added by Dubuque Bank And Trust Co
By: LUCILLE CHAMBERS Approving Editor: DAVID ANDERSON
LONG BEACH (Mffais.com) - Dubuque Bank And Trust Co added the Deep Down Inc (DPDW.PK) company to their portfolio, by buying 2,721,188 shares as shown by filings made public on 2008-07-22.
The stock is currently owned by 2 funds/institutions with a total activity score of 1.50. With 100.00 % of owning funds reported recently buying shares, 0.00 % maintaining existing share level and 0.00 % selling shares. Full details for Deep Down Inc (DPDW.PK) available at http://www.mffais.com/dpdw.pk.html
There are much better oil plays IHMO - but as you said - this can be good too - but first oil have to settle down and then it is buy - now surely not (with so big volatility in commodities esp. oil) - good luck with that one :)
thanks for that Joe
Hard to say - nobody knows - if we will see some good news after closing this deal - I guess yes - if not - we are here for long run :)
I agree with you, but they have lost credibility - I also believe in that future plans Larry has, but there is still lost credibility out there - I also believe, that they won´t rise the A/S now when they ungagged it - it would be suicide for them - But again the credibility question is here - You know why we are all asking almost every day about A/S - because we are now care full - we believed them and we are now in loss (or at least I am :)) It will take weeks, months until I will believe them again - And before I buy again, I will always want to check the A/S - Daily report about A/S is probably almost insane, but weekly report would be fine